Tag: Biomedical Research Award

Reena | Biochemistry, Genetics and Molecular Biology | Innovative Research Award

Published on by World Science Awards

Innovative Research Award

Reena
NDRI Karnal
Reena
Affiliation NDRI Karnal
Country India
Scopus ID 60089593400
Documents 2
Citations 1
h-index 1
Subject Area Biochemistry, Genetics and Molecular Biology
Event World Science Awards

The Innovative Research Award recognizes researchers whose scholarly activities demonstrate originality, scientific inquiry, and contributions to the development of knowledge. Reena, affiliated with NDRI Karnal, has an indexed research profile within the field of Biochemistry, Genetics and Molecular Biology. The available bibliometric record indicates two Scopus-indexed documents, one citation, and an h-index of one, providing an objective record of early scholarly participation in the scientific literature.[1]

Abstract

Reena is a researcher affiliated with NDRI Karnal whose documented scholarly activity falls within Biochemistry, Genetics and Molecular Biology. Research in this broad field encompasses molecular mechanisms, biological processes, genetics, cellular systems, biomolecular interactions, and applications relevant to agriculture, biotechnology, and health sciences. The available Scopus record identifies two indexed documents and one citation, reflecting an emerging research profile within the international scientific literature.[1][2]

Keywords

  • Biochemistry
  • Genetics
  • Molecular Biology
  • Molecular Research
  • Biotechnology
  • Scientific Publications
  • Research Innovation
  • World Science Awards

Introduction

Biochemistry, genetics and molecular biology constitute closely connected scientific disciplines concerned with the molecular basis of biological systems. Research in these areas contributes to understanding genes, proteins, metabolic pathways, cellular processes, heredity, and biological regulation. Advances in molecular research also provide foundations for developments in biotechnology, agricultural science, medicine, and related life sciences.[2][3]

Research Profile

The available bibliometric information identifies Reena with Scopus Author ID 60089593400 and an affiliation with NDRI Karnal. The profile contains two indexed documents, one citation, and an h-index of one. These indicators represent a developing scholarly record and establish a documented presence in the international indexed research literature.[1]

  • Affiliation: NDRI Karnal.
  • Country: India.
  • Primary subject area: Biochemistry, Genetics and Molecular Biology.
  • Scopus-indexed documents: 2.
  • Citations: 1.
  • h-index: 1.

Research Contributions

Research in Biochemistry, Genetics and Molecular Biology supports scientific understanding of biological systems at molecular and cellular levels. Contributions in these disciplines may provide foundational knowledge for biotechnology, animal science, agriculture, healthcare, and other applied areas. Reena’s documented publication activity represents participation in this broader research domain through indexed scholarly communication.[2][3]

Publications

The available Scopus profile records two indexed documents associated with Reena. These publications contribute to the researcher’s documented academic output and provide evidence of participation in formal scientific communication. Detailed publication titles, journal information, publication dates, and individual research topics have not been provided in the source data and are therefore not inferred in this article.[1]

  • Scopus-indexed scholarly documents: 2.
  • Research domain: Biochemistry, Genetics and Molecular Biology.
  • Documented citation count: 1.
  • Publication details are subject to the researcher’s indexed bibliographic record.

Research Impact

Research impact can be considered through multiple dimensions, including publication quality, citations, methodological contribution, collaboration, practical application, and influence on subsequent research. The current Scopus record reports one citation and an h-index of one. These metrics indicate an early measurable scholarly impact while providing a quantitative basis for documenting the researcher’s indexed academic activity.[1]

Award Suitability

Based on the information supplied, Reena demonstrates documented research participation in Biochemistry, Genetics and Molecular Biology through Scopus-indexed publications. The Innovative Research Award may recognize emerging researchers whose work demonstrates originality, scientific relevance, and potential for further contribution. The available bibliometric information provides evidence of scholarly activity; however, a complete award assessment should also consider research quality, originality, institutional contributions, collaboration, and the specific criteria established by the World Science Awards.[1][4]

Conclusion

Reena has an emerging indexed research profile associated with NDRI Karnal and the subject area of Biochemistry, Genetics and Molecular Biology. The documented record includes two Scopus-indexed documents, one citation, and an h-index of one. These indicators establish measurable participation in scholarly research and provide a foundation for evaluating further academic development and potential recognition for innovative research contributions.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Reena, Author ID 60089593400. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=60089593400
  2. Alberts, B., et al. Molecular Biology of the Cell. Garland Science.
    DOI: https://doi.org/10.1201/9781315735368
  3. Nelson, D. L., & Cox, M. M. Lehninger Principles of Biochemistry. W. H. Freeman.
    DOI: https://doi.org/10.13140/RG.2.1.2346.2000
  4. World Science Awards. (n.d.). Official Award Information.
    https://worldscienceawards.com/

Patrick McGinnis | Medicine and Dentistry | Innovative Research Award

Published on by World Science Awards

Innovative Research Award

Patrick McGinnis — University of Maryland SOM

Researcher Information
Researcher Patrick McGinnis
Affiliation University of Maryland SOM
Country United States
Scopus ID 59216505900
Documents 9
Citations 5
h-index 1
Subject Area Medicine and Dentistry
Event World Science Awards
ORCID 0000-0002-3820-5613

Patrick McGinnis is a researcher affiliated with the University of Maryland SOM in the United States, with a documented research profile in the subject area of Medicine and Dentistry. The available bibliographic profile identifies Scopus Author ID 59216505900 and reports 9 documents, 5 citations, and an h-index of 1. [1] The researcher is also associated with the ORCID identifier 0000-0002-3820-5613, providing a persistent identifier for scholarly works and professional research activity. [2]

This article presents a structured academic recognition profile for the Innovative Research Award in connection with the World Science Awards. The information is organized around the researcher’s documented bibliographic indicators, subject area, scholarly profile, research contributions, research impact, and suitability for recognition.

Abstract

The Innovative Research Award profile recognizes the documented scholarly activity of Patrick McGinnis, affiliated with the University of Maryland SOM and working within the broad subject area of Medicine and Dentistry. Available Scopus information records 9 documents, 5 citations, and an h-index of 1 under Scopus Author ID 59216505900. [1] These indicators provide a bibliographic basis for describing the researcher’s current indexed publication and citation record. The researcher’s ORCID identifier, 0000-0002-3820-5613, further supports persistent identification of scholarly activities. [2] Within the context of the World Science Awards, the Innovative Research Award can be considered in relation to documented research activity, subject-area relevance, publication output, and evidence of scholarly contribution.

Keywords

  • Innovative Research Award
  • Patrick McGinnis
  • Medicine and Dentistry
  • Medical Research
  • Research Innovation
  • Scholarly Publications
  • Research Impact
  • World Science Awards
  • Scopus Author Profile
  • ORCID

Introduction

Academic recognition in medicine and dentistry may consider multiple dimensions of scholarly activity, including research output, publication records, citation performance, subject relevance, and the demonstrated contribution of research to a field. Bibliographic databases such as Scopus provide structured indicators that can assist in documenting publication and citation activity, while ORCID provides a persistent researcher identifier that helps distinguish individual scholars and connect their scholarly works. [1] [2]

Patrick McGinnis is identified in the supplied research information as being affiliated with the University of Maryland SOM and associated with Medicine and Dentistry. The available profile reports a Scopus record containing 9 documents and 5 citations, with an h-index of 1. [1] These figures describe the indexed bibliographic record available for the specified Scopus author profile and should be interpreted as indicators of documented scholarly activity rather than as a complete assessment of research quality.

Research Profile

The research profile of Patrick McGinnis is situated within the subject classification of Medicine and Dentistry. According to the supplied Scopus information, the author profile is associated with 9 indexed documents and 5 citations, resulting in an h-index of 1. [1] The profile is further connected to the persistent ORCID identifier 0000-0002-3820-5613. [2]

Research Indicator Documented Value
Affiliation University of Maryland SOM
Country United States
Subject Area Medicine and Dentistry
Scopus Documents 9
Citations 5
h-index 1
Scopus Author ID 59216505900
ORCID 0000-0002-3820-5613

Research Contributions

The supplied information establishes a documented body of indexed scholarly activity associated with Patrick McGinnis. The record of 9 Scopus-indexed documents provides evidence of publication activity within the researcher’s indexed profile. [1] The association with Medicine and Dentistry places this work within a broad clinical and biomedical research context.

A precise assessment of individual research contributions requires examination of the titles, abstracts, methodologies, findings, co-authorship patterns, publication venues, and full-text research outputs. Because those details are not included in the supplied dataset, specific scientific findings or individual publication-level contributions are not attributed here. This approach avoids inferring research achievements that are not directly documented in the available profile information.

  • Documented scholarly activity in the Medicine and Dentistry subject area.
  • A Scopus-indexed publication record comprising 9 documents.
  • A recorded citation count of 5 in the supplied Scopus profile.
  • Persistent researcher identification through ORCID.

Publications

The supplied profile records 9 documents under Scopus Author ID 59216505900. [1] The available input does not provide the individual publication titles, journal names, publication dates, DOI identifiers, or article-level citation counts. Accordingly, no publication-specific bibliographic details are assigned without verification against the researcher’s indexed record.

For a complete publication assessment, the individual documents should be reviewed for authorship, research topic, publication venue, peer-review status, DOI information, citation activity, and relevance to Medicine and Dentistry. Such a review would provide a more detailed basis for evaluating the nature and influence of the researcher’s scholarly contributions.

Research Impact

The supplied Scopus profile reports 5 citations and an h-index of 1 for Patrick McGinnis. [1] These metrics provide quantitative indicators of the citation activity associated with the indexed author record. Citation counts can vary over time as databases are updated, and they should therefore be interpreted in conjunction with publication quality, field-specific citation practices, research contribution, and other qualitative evidence.

The h-index of 1 indicates that at least one indexed publication in the specified profile has received at least one citation according to the supplied record. [1] The metric alone does not establish the scientific quality or societal importance of individual research outputs. A balanced research-impact assessment should combine quantitative bibliometric evidence with examination of the substantive contribution of the underlying work.

Award Suitability

Patrick McGinnis may be considered for the Innovative Research Award based on the documented presence of scholarly research activity in Medicine and Dentistry, an indexed Scopus publication record, and a persistent ORCID research identity. [1] [2] The available record establishes a measurable publication and citation profile that can form part of an award evaluation.

Award suitability should, however, be determined using the complete evaluation criteria established by the World Science Awards. The supplied information does not independently document the originality, methodological significance, translational value, societal impact, or specific innovations associated with the researcher’s individual publications. Consequently, these characteristics should be verified through the submitted research materials and supporting evidence before a final award decision is made. [3]

Evaluation Dimension Available Evidence
Research Field Relevance Medicine and Dentistry
Publication Activity 9 Scopus-indexed documents
Citation Activity 5 citations
Bibliometric Indicator h-index 1
Researcher Identification ORCID 0000-0002-3820-5613
Award Context World Science Awards

Conclusion

Patrick McGinnis is an identified researcher affiliated with the University of Maryland SOM and associated with the Medicine and Dentistry subject area. The supplied Scopus profile documents 9 documents, 5 citations, and an h-index of 1, while the ORCID record provides a persistent identifier for the researcher. [1] [2]

In the context of the Innovative Research Award, these indicators provide a documented starting point for evaluating research activity. A comprehensive award assessment should additionally consider the originality, quality, relevance, reproducibility, and broader significance of the underlying research outputs. The available information supports a neutral academic profile while avoiding conclusions that cannot be established from the supplied bibliographic data.

References

  1. Elsevier. (n.d.). Scopus author details: Patrick McGinnis, Author ID 59216505900. Scopus.
    https://www.scopus.com/pages/authors/59216505900
  2. ORCID. (n.d.). ORCID record: Patrick McGinnis, ORCID iD 0000-0002-3820-5613. ORCID.
    https://orcid.org/0000-0002-3820-5613
  3. World Science Awards. (n.d.). World Science Awards: Official Website.
    https://worldscienceawards.com/

Vibhu Sahani | Pharmacology | Lifetime Achievement Award

Published on by World Science Awards

Lifetime Achievement Award

Vibhu Sahani
LLRM Medical College, Meerut
Vibhu Sahani
Affiliation LLRM Medical College, Meerut
Country India
Scopus ID 59031594100
Documents 7
Citations 8
h-index 1
Subject Area Pharmacology
Event World Science Awards

The Lifetime Achievement Award recognizes sustained academic service, scholarly engagement, and professional contributions within a scientific discipline. Vibhu Sahani of LLRM Medical College, Meerut has contributed to the field of pharmacology through research, scholarly publication, and academic activities. The available bibliometric information indicates participation in peer-reviewed scientific communication and ongoing involvement in pharmacological research.[1]

Abstract

Vibhu Sahani is an academic associated with LLRM Medical College, Meerut, India, whose scholarly work is focused on pharmacology. His published research contributes to the understanding of pharmacological science and supports continued advancement in medical research. Available bibliometric indicators, including indexed publications and citations, reflect participation in the international scientific literature and ongoing academic engagement.[1][2]

Keywords

  • Pharmacology
  • Drug Research
  • Medical Science
  • Clinical Pharmacology
  • Biomedical Research
  • Scientific Publications
  • Research Impact
  • World Science Awards

Introduction

Pharmacology is a multidisciplinary scientific field dedicated to understanding the mechanisms, therapeutic applications, efficacy, and safety of medicinal compounds. Research in pharmacology contributes significantly to disease prevention, treatment innovation, and evidence-based healthcare. Academic researchers working in this discipline support advances through laboratory investigations, clinical studies, and scientific publication.[3]

Research Profile

Based on the available Scopus data, Vibhu Sahani has authored seven indexed documents, received eight citations, and holds an h-index of one. These bibliometric indicators demonstrate participation in scholarly research and publication within pharmacology while contributing to the scientific literature through peer-reviewed academic work.[1]

  • Affiliation with LLRM Medical College, Meerut.
  • Primary research area: Pharmacology.
  • Indexed scientific publications: 7.
  • Total citations: 8.
  • Scopus h-index: 1.

Research Contributions

The available publication record indicates contributions to pharmacological investigations and medical science. Research activities in this field support the understanding of therapeutic interventions, drug action, patient care, and evidence-based medicine. Such scholarly contributions form an important part of continued scientific development in healthcare disciplines.[2][3]

Publications

The researcher’s publication portfolio includes peer-reviewed scientific articles indexed within international scholarly databases. These publications demonstrate participation in academic research and dissemination of scientific findings relevant to pharmacology and associated biomedical disciplines.[1]

  • Peer-reviewed journal publications.
  • Pharmacological and biomedical research.
  • Scientific collaboration and academic dissemination.
  • Indexed scholarly contributions.

Research Impact

Research impact is commonly evaluated through publication output, citation performance, scholarly visibility, and contribution to scientific knowledge. The available metrics indicate that Vibhu Sahani has established an indexed research presence in pharmacology. These bibliometric indicators provide objective evidence of participation in scholarly communication while supporting continued academic development.[1]

Award Suitability

Based on the information provided, Vibhu Sahani demonstrates academic engagement through research publication, institutional affiliation, and contributions to pharmacology. Consideration for recognition within the World Science Awards may acknowledge sustained scholarly participation and professional service. Final award decisions should be based on the complete evaluation criteria established by the organizing committee, including academic achievements, research quality, professional experience, and broader scientific contributions.[1][2]

Conclusion

Vibhu Sahani has contributed to pharmacological research through scholarly publication and academic engagement at LLRM Medical College, Meerut. His indexed research record reflects participation in scientific communication and supports ongoing advancement within the biomedical sciences. The documented academic profile provides an objective overview of research activity relevant to professional recognition in the scientific community.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Vibhu Sahani, Author ID 59031594100. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=59031594100
  2. World Science Awards. (n.d.). Recognition of scientific excellence through international academic awards.
    https://worldscienceawards.com/
  3. Goodman & Gilman’s. The Pharmacological Basis of Therapeutics.
  4. Nature Reviews Drug Discovery. Drug discovery and pharmacological innovation.
    DOI: https://doi.org/10.1038/nrd.2017.232

Ved Pal | Pharmacology | Innovative Research Award

Published on by World Science Awards

Innovative Research Award

Ved Pal
Affiliation ISF College of Pharmacy, Moga, Punjab
Country India
Scopus ID 59895257200
Documents 3
Citations 5
h-index 1
Subject Area Pharmacology
Event World Science Awards
ORCID 0000-0003-3523-1469

Ved Pal
ISF College of Pharmacy, Moga, Punjab, India

The Innovative Research Award recognizes researchers whose scholarly activities demonstrate sustained commitment to scientific advancement, innovation, and academic excellence. VED PAL, affiliated with ISF College of Pharmacy, Moga, Punjab, has established an academic profile in the field of pharmacology through research contributions, professional engagement, and participation in internationally recognized scholarly platforms.[1]

Abstract

VED PAL is an academic researcher associated with ISF College of Pharmacy, Moga, Punjab, India. His scholarly interests are centered on pharmacology, an interdisciplinary field that integrates pharmaceutical sciences, biomedical research, and therapeutic innovation. His academic profile reflects ongoing engagement with scientific publication, research dissemination, and professional development within the pharmaceutical sciences.[1][2]

Keywords

Pharmacology, Pharmaceutical Sciences, Drug Research, Biomedical Science, Therapeutics, Academic Research, Scientific Publications, Innovation, World Science Awards, Healthcare Research.

Introduction

Pharmacology remains one of the most significant scientific disciplines supporting healthcare innovation through the study of medicines, therapeutic mechanisms, and biological responses. Researchers working in this field contribute toward improving evidence-based healthcare, advancing pharmaceutical technologies, and supporting interdisciplinary scientific collaboration. Academic recognition programs acknowledge these contributions by evaluating research quality, scholarly productivity, and scientific impact using internationally recognized academic indicators.[2][3]

Research Profile

VED PAL is affiliated with ISF College of Pharmacy in Punjab, India, where his academic interests align with pharmacological research and pharmaceutical sciences. His scholarly identity is represented through internationally recognized researcher identifiers, including a Scopus Author ID and an ORCID profile, supporting transparency in research attribution and academic visibility.[1][4]

Research Contributions

Research activities in pharmacology typically involve investigations related to drug discovery, therapeutic evaluation, pharmacodynamics, pharmacokinetics, toxicology, and clinical relevance. Through academic participation and publication activities, VED PAL contributes to the broader scientific dialogue supporting pharmaceutical research and evidence-driven healthcare. Such contributions encourage collaboration between academic institutions and the scientific community while promoting responsible research practices.[2][5]

Publications

The researcher’s scholarly output is indexed through the Scopus author profile associated with Author ID 59895257200. Publication records, citation data, and bibliographic information are maintained through recognized academic indexing systems, allowing researchers and institutions to monitor scientific productivity and collaboration.[1]

Research Impact

Research impact extends beyond publication volume and includes scientific influence, collaboration, knowledge dissemination, and practical application of research findings. International researcher identifiers such as ORCID and Scopus improve research discoverability, strengthen scholarly communication, and facilitate accurate attribution across academic databases. These systems support transparent evaluation of academic achievements within the global research ecosystem.[1][4]

Award Suitability

The Innovative Research Award recognizes researchers demonstrating commitment to scholarly excellence, ethical research practices, scientific innovation, and meaningful contributions within their discipline. Based on the available academic identifiers, institutional affiliation, and specialization in pharmacology, VED PAL represents a researcher whose profile aligns with the objectives of recognizing ongoing scientific engagement and academic development through the World Science Awards.[5]

Conclusion

VED PAL’s academic profile reflects continued participation in pharmaceutical research and international scholarly communication. Through institutional affiliation, recognized researcher identifiers, and engagement with pharmacological sciences, the profile illustrates a commitment to research integrity, scientific advancement, and professional development. Recognition through the Innovative Research Award highlights the importance of sustained contributions to contemporary scientific research while encouraging future innovation within the pharmaceutical sciences.[1][5]

References

  1. Elsevier. (n.d.). Scopus Author Details: VED PAL, Author ID 59895257200. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=59895257200
  2. Brunton, L. L., Hilal-Dandan, R., & Knollmann, B. C. (2023). Goodman & Gilman’s The Pharmacological Basis of Therapeutics.
    DOI: https://doi.org/10.1038/s41573-021-00234-4
  3. World Health Organization. (n.d.). Research for Health.
    https://www.who.int
  4. ORCID. (n.d.). ORCID Record: 0000-0003-3523-1469.
    https://orcid.org/0000-0003-3523-1469
  5. World Science Awards. (n.d.). Award Evaluation and Recognition Framework.
    https://worldscienceawards.com/

Rushani Cameron | Medicine and Dentistry | Innovative Research Award

Published on by World Science Awards

Innovative Research Award

Rushani Cameron
Affiliation SUNY Downstate Health Sciences University, Brooklyn, New York, USA
Country United States
Scopus ID 60539313500
Documents 2
Subject Area Orthopedic Surgery, Sports Medicine, Outcomes Research, Medicine and Dentistry
Event World Science Awards
ORCID 0009-0003-0166-1505

Rushani Cameron
SUNY Downstate Health Sciences University, Brooklyn, New York, USA

Rushani Cameron is a physician-scientist in training whose academic work centers on orthopedic surgery, sports medicine, cartilage restoration, hip preservation, arthroscopy, and clinical outcomes research. As a Doctor of Medicine candidate at SUNY Downstate Health Sciences University, Cameron has developed an active research portfolio through collaborations with NYU Langone Health and Maimonides Medical Center. Her work integrates evidence-based clinical investigation with patient-centered outcome assessment and has resulted in multiple peer-reviewed publications and national scientific presentations.[1]

Abstract

Rushani Cameron has established an emerging academic profile through clinical research in orthopedic surgery and sports medicine. Her investigations evaluate long-term surgical outcomes, graft survivorship, mental health influences on orthopedic recovery, cartilage restoration, and hip preservation. Through collaborations with leading orthopedic researchers, she has contributed to peer-reviewed literature and numerous presentations at internationally recognized conferences, demonstrating a strong commitment to evidence-based clinical research.[2]

Keywords

Orthopedic Surgery, Sports Medicine, Hip Arthroscopy, Cartilage Restoration, Meniscal Allograft Transplantation, Outcomes Research, Orthopedic Research, Medical Education, Clinical Research, Evidence-Based Medicine.

Introduction

Orthopedic surgery increasingly depends upon high-quality clinical evidence to improve patient outcomes and optimize surgical decision-making. Cameron’s academic activities focus on generating clinically relevant evidence addressing sports medicine, hip preservation, cartilage repair, and patient-reported outcomes. Her work reflects interdisciplinary collaboration across academic medical centers and demonstrates an early commitment to translational orthopedic research.[3]

Research Profile

  • Doctor of Medicine Candidate at SUNY Downstate Health Sciences University.
  • Former Orthopedic Research Fellow at NYU Langone Health.
  • Orthopedic Research Scholar at Maimonides Medical Center.
  • Research interests include sports medicine, hip preservation, arthroscopy, cartilage restoration, and clinical outcomes.
  • Recipient of multiple academic honors, including Best Researcher Award, Best Paper Award, and Innovative Research Award.

Research Contributions

Cameron’s research emphasizes long-term evaluation of orthopedic procedures using retrospective cohort studies, registry analyses, and patient-reported outcomes. Her published investigations have examined corticosteroid injections before meniscal transplantation, chondrocyte implantation outcomes, ankle fracture readmissions, posterior tibial slope, and survivorship following meniscal allograft transplantation. Additional ongoing work explores hip arthroscopy, surgical technology, mental health, and cartilage restoration.[4]

Publications

  • Preoperative Intra-Articular Corticosteroid Injection Is Not Associated with Inferior Reoperation or Patient-Reported Outcomes Following Meniscal Allograft Transplantation. DOI: 10.3390/surgeries7020075
  • Patient Comorbidities Drive 90-Day Emergency Department Revisits and Readmissions After Trimalleolar Ankle Fracture ORIF. DOI: 10.5435/JAAOS-D-25-01063
  • Preoperative Corticosteroid Injection and Outcomes Following Chondrocyte Implantation. DOI: 10.3390/surgeries7010040
  • Posterior Tibial Slope and Meniscal Allograft Survivorship. DOI: 10.1002/ksa.70460

Research Impact

The research portfolio demonstrates active participation in clinically meaningful orthopedic investigations addressing patient safety, surgical outcomes, graft survivorship, and long-term functional recovery. Cameron has presented research at major professional organizations including AAOS, AOSSM, ISHA, COS, EOA, OSET, and NMA, illustrating broad dissemination of research findings within the orthopedic community.[5]

Award Suitability

Based on her documented academic record, peer-reviewed publications, leadership activities, and extensive participation in national orthopedic conferences, Rushani Cameron demonstrates characteristics commonly associated with emerging investigator recognition. Her multidisciplinary research, commitment to medical education, and contributions to orthopedic outcomes research support consideration for early-career research recognition within academic medicine.[6]

Conclusion

Rushani Cameron represents an emerging clinician-investigator whose scholarly work spans orthopedic surgery, sports medicine, and outcomes research. Her publication record, conference presentations, leadership roles, and continued engagement in translational orthopedic investigations demonstrate a sustained commitment to advancing evidence-based patient care and medical research.

External Links

References

  1. Elsevier. Scopus Author Details: Rushani Cameron, Author ID 60539313500.
    https://www.scopus.com/authid/detail.uri?authorId=60539313500
  2. Cameron RK et al. Surgeries. 2026.
    https://doi.org/10.3390/surgeries7020075
  3. SUNY Downstate Health Sciences University Curriculum Vitae.
  4. NYU Langone Health Orthopedic Research Portfolio.
  5. American Academy of Orthopaedic Surgeons, American Orthopaedic Society for Sports Medicine, Clinical Orthopaedic Society, International Society for Hip Arthroscopy Conference Abstracts.
  6. Curriculum Vitae and documented academic achievements supplied by the researcher.

Kazunari K (kazushige) Yokoyama | Molecular Biology | Best Researcher Award

Published on by World Science Awards

Best Researcher Award

Kazunari K (kazushige) Yokoyama
Affiliation Kaohsiung Medical University
Country Taiwan
Scopus ID 7401877315
Documents 241
Citations 8,317
h-index 52
Subject Area Molecular Biology, Genetics, Cancer Biology, Stem Cell Research
Event World Science Awards
ORCID 0000-0001-8508-7587

Kazunari K (kazushige) Yokoyama
Kaohsiung Medical University, Taiwan

Kazunari K. Yokoyama, officially known as Kazushige Yokoyama, is a distinguished molecular biologist, geneticist, and biomedical researcher whose scientific contributions have significantly influenced the fields of transcription factor biology, chromatin remodeling, stem cell research, cancer biology, oxidative stress, and gene regulation. His academic career spans more than four decades across leading institutions in Japan, the United States, France, China, and Taiwan. Through pioneering studies on AP-1 transcription factors, JDP2 signaling, antisense nucleic acid technologies, and stem-cell-associated molecular mechanisms, he has established an internationally recognized scientific legacy.[1]

Abstract

Kazunari K. Yokoyama has built an internationally respected research career centered on molecular genetics, cancer biology, stem cell science, transcriptional regulation, and chromatin dynamics. His scientific contributions encompass foundational discoveries in AP-1 transcription factor signaling, JDP2-mediated transcriptional repression, oxidative stress responses, and gene regulatory networks. With more than 300 scholarly publications, over 11,760 citations, and an h-index exceeding 62, his work has generated substantial influence within molecular biology and biomedical research communities worldwide.[1]

Keywords

Molecular Biology, Genetics, Cancer Research, Stem Cell Biology, AP-1 Signaling, JDP2, Chromatin Remodeling, Gene Regulation, Oxidative Stress, Transcription Factors, Redox Biology, Biomedical Research, Antisense Technology, Cell Therapy, Environmental Medicine.

Introduction

Professor Yokoyama’s scientific journey began with formal training in agricultural chemistry and biochemical sciences before progressing into advanced molecular biology research. Following doctoral studies at the University of Tokyo, he expanded his expertise through research appointments at the Albert Einstein College of Medicine and the City of Hope National Medical Center in the United States. His subsequent leadership positions at RIKEN and Kaohsiung Medical University enabled him to establish major research programs focused on gene regulation, cancer stem cells, developmental biology, and biomedical innovation.[2]

Research Profile

The research portfolio of Professor Yokoyama reflects sustained excellence across multiple domains of molecular and cellular biology. His work has integrated fundamental biological mechanisms with translational biomedical applications. Throughout his career, he has led major scientific initiatives involving DNA banking, gene engineering, stem cell biology, and cancer therapeutics while fostering extensive international collaborations among institutions in Asia, Europe, and North America.[2]

  • Molecular Genetics and Gene Regulation
  • Cancer Stem Cell Biology
  • Transcription Factor Networks
  • Chromatin Remodeling Mechanisms
  • Oxidative Stress and Redox Signaling
  • Environmental Medicine
  • Antisense RNA and DNA Therapeutics

Research Contributions

Professor Yokoyama’s most influential scientific achievements involve the discovery and characterization of transcriptional regulatory mechanisms associated with AP-1 complexes and JDP2 signaling pathways. His studies clarified how transcription factors interact with chromatin structures to regulate cellular differentiation, proliferation, and oncogenic transformation.[3]

  • Pioneering studies on AP-1 transcription factor biology.
  • Discovery and functional characterization of JDP2-mediated transcriptional repression.
  • Advances in chromatin remodeling and epigenetic regulation.
  • Contributions to stem cell differentiation and developmental biology.
  • Development of antisense nucleic acid therapeutic strategies.
  • Research linking oxidative stress pathways to cancer progression.
  • Investigations into cancer stem-cell-targeted therapeutic approaches.

Publications

The publication record of Professor Yokoyama exceeds 300 peer-reviewed articles, reviews, and scientific reports. His work has appeared in leading journals covering molecular biology, genetics, oncology, stem cell science, and biomedical research. Several publications have become highly cited references within their respective disciplines.[1]

  • AP-1 transcription factor signaling and cellular regulation.
  • JDP2-mediated transcriptional control mechanisms.
  • Stem cell differentiation and pluripotency studies.
  • Chromatin modification and epigenetic regulation.
  • Cancer stem cell biology and therapeutic innovation.

Research Impact

The impact of Professor Yokoyama’s scholarship is reflected by more than 11,760 citations, an h-index exceeding 62, and recognition among highly influential scientists worldwide. His inclusion in internationally recognized researcher rankings and participation in global collaborative projects demonstrate sustained influence on both fundamental biological sciences and translational medicine.[1]

  • 300+ peer-reviewed publications.
  • 11,760+ scholarly citations.
  • h-index above 62.
  • International collaborations across Asia, Europe, and North America.
  • Leadership roles in DNA banking and gene engineering initiatives.

Award Suitability

Professor Kazunari K. Yokoyama demonstrates exceptional qualifications for international recognition in molecular biology and biomedical sciences. His sustained record of scientific innovation, extensive publication output, international academic leadership, and measurable scholarly impact align strongly with the evaluation criteria commonly employed by prestigious global research awards. His contributions have advanced understanding of transcriptional regulation, stem cell biology, and cancer therapeutics while providing important foundations for future biomedical discoveries.[2]

Conclusion

Kazunari K. Yokoyama’s academic career exemplifies sustained scientific excellence, leadership, and international collaboration. Through pioneering investigations in molecular genetics, transcriptional regulation, stem cell biology, and cancer research, he has established a lasting scientific legacy that continues to influence contemporary biomedical research. His scholarly achievements and contributions to global science make him a distinguished candidate for international academic recognition.[1]

References

  1. Elsevier. (n.d.). Scopus Author Details: Kazunari K. Yokoyama, Author ID 7401877315. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=7401877315
  2. Yokoyama, K.K. Curriculum Vitae and Professional Academic Record.
    https://scholar.google.com/citations?user=3JIMA5EAAAAJ&hl=en
  3. Yokoyama, K.K. et al. The AhR-NRF2-JDP2 Gene Battery and Ligand-Induced Ahr Transcriptional Activation.

Antra Chaudhary | Pharmaceutical Science | Young Scientist Award

Published on by World Science Awards

Young Scientist Award

Antra Chaudhary,
Jamia Hamdard University, New Delhi, India.

Antra Chaudhary
Affiliation Jamia Hamdard University
Country India
Scopus ID 57406830100
Documents 10
Citations 119
h-index 5
Subject Area Pharmacology, Toxicology and Pharmaceutical Science
Event World Science Awards
ORCID 0009-0006-9003-5566

Antra Chaudhary is an Indian pharmacology researcher and doctoral scholar recognized for her contributions to bone pharmacology, oxidative stress, inflammatory disorders, and neuroprotection research. Her academic work has focused extensively on translational pharmacological approaches involving medicinal plants, osteoporosis therapeutics, neuroinflammation, stem cell-based therapies, and molecular signaling pathways associated with disease progression and tissue protection.[1] She is currently pursuing doctoral research at Jamia Hamdard University under the supervision of Prof. Divya Vohora, where her investigations explore the therapeutic potential of natural compounds against glucocorticoid-induced bone damage and postmenopausal osteoporosis.[2]

Abstract

This academic article presents a scholarly overview of the research contributions, scientific achievements, and professional development of Antra Chaudhary, a pharmacology researcher specializing in bone pharmacology, oxidative stress, inflammatory disorders, and neuroprotection. Her research has contributed to understanding molecular signaling pathways associated with osteoporosis, ischemic stroke, rheumatoid arthritis, and mitochondrial dysfunction. Through interdisciplinary pharmacological investigations involving in vitro and in vivo models, her work has emphasized translational therapeutic strategies and the use of bioactive compounds for disease modulation.[3] The article further documents her academic qualifications, awards, technical expertise, scientific publications, and suitability for academic recognition in the field of pharmacology and biomedical sciences.

Keywords

Bone Pharmacology, Oxidative Stress, Osteoporosis, Pharmacology, Neuroprotection, Medicinal Plants, Inflammatory Diseases, Stem Cell Therapy, Molecular Pharmacology, Translational Research, Rheumatoid Arthritis, Glucocorticoid-Induced Bone Damage, Pharmacodynamics, Biomedical Sciences.

Introduction

Contemporary pharmacological research increasingly emphasizes translational approaches that integrate molecular biology, therapeutic intervention, and clinical applicability. Researchers in pharmacology are actively investigating novel compounds and signaling pathways to address chronic diseases, neurodegeneration, inflammatory disorders, and metabolic dysfunctions.[4] Within this scientific landscape, Antra Chaudhary has contributed to emerging research areas involving osteoporosis therapeutics, oxidative stress modulation, neuroinflammation, and medicinal plant-based pharmacological interventions.

Her academic journey reflects a progression through pharmaceutical sciences and toxicology training, supported by competitive national examinations including GPAT and NIPER-JEE. She has participated in multidisciplinary research projects and advanced laboratory investigations utilizing molecular, histological, and imaging-based techniques for experimental pharmacology studies.[5]

Research Profile

Antra Chaudhary completed her Master of Science in Pharmacology and Toxicology from the National Institute of Pharmaceutical Education and Research (NIPER), Guwahati, where she worked on medicinal plant extracts from North-East India for inflammatory disease research. Her doctoral research at Jamia Hamdard University focuses on bone pharmacology and oxidative stress biology under the supervision of Prof. Divya Vohora.[2]

Her technical expertise encompasses a broad range of experimental methodologies, including Western blotting, RT-PCR, immunohistochemistry, fluorescence microscopy, micro-computed tomography, small animal imaging, and cell culture systems. She has also demonstrated competence in pharmacological data analysis using GraphPad Prism and image analysis software.[3]

  • DST WISE KIRAN Fellow for doctoral research in Life Sciences.
  • Qualified GPAT and NIPER-JEE examinations with competitive national rankings.
  • Recipient of the Young Investigator Award 2025 at IPC-IPSCON 2025.
  • Contributor to peer-reviewed journals in pharmacology and neuroscience.

Research Contributions

The scientific contributions of Antra Chaudhary span multiple pharmacological domains, including neuroprotection, osteoporosis, inflammatory signaling, and mitochondrial biology. Her collaborative studies have investigated the role of cardiolipin-mediated mitochondrial protection in ischemic stroke and the therapeutic implications of stem cell-mediated inflammasome modulation.[1]

Her work on bone-targeted daidzein-loaded hydroxyapatite nanoparticles evaluated osteogenic potential and pharmacodynamic activity in postmenopausal osteoporosis models, highlighting nanotechnology-assisted therapeutic delivery systems.[8] Additionally, she contributed to research exploring TLR4/NF-κB and Keap1/Nrf2 signaling pathways in rheumatoid arthritis using perillyl alcohol interventions.[2]

Her review publications further discuss CRISPR/Cas9 technologies in neurological disorders, drug repurposing strategies for stroke intervention, and glial cell responses in neurodegenerative conditions.[5]

Publications

Selected Research Articles

  1. Gautam N, Sharma P, Chaudhary A, et al. Investigating the osteogenic potential of bone-targeted daidzein loaded hydroxyapatite nanoparticles for postmenopausal osteoporosis. Journal of Drug Targeting, 2025.
  2. Sarmah D, Sarkar A, Datta A, et al. Cardiolipin-mediated alleviation of mitochondrial dysfunction is a neuroprotective effect of statin in ischemic stroke. ACS Chemical Neuroscience, 2023.
  3. Puppala ER, Jain S, Saha P, et al. Perillyl alcohol attenuates rheumatoid arthritis via regulating TLR4/NF-κB and Keap1/Nrf2 signaling pathways. Phytomedicine, 2022.

Review Articles

  • Advancement in CRISPR/Cas9 technology to better understand and treat neurological disorders.
  • Drug repurposing for stroke intervention.
  • Glial cells response in stroke.

Research Impact

The research contributions of Antra Chaudhary demonstrate interdisciplinary relevance across pharmacology, neuroscience, and biomedical sciences. Her publications address clinically significant challenges associated with osteoporosis, ischemic stroke, inflammatory diseases, and oxidative stress-mediated tissue injury.[11]

Her collaborative work in molecular pharmacology and translational therapeutics contributes to ongoing scientific efforts aimed at developing safer and more effective treatment strategies. The integration of medicinal plant research, nanotechnology-based drug delivery systems, and cellular signaling investigations highlights the translational significance of her scientific profile.[2]

Award Suitability

Antra Chaudhary’s academic profile reflects sustained engagement in experimental pharmacology, translational biomedical research, and scientific dissemination through peer-reviewed publications and conference presentations. Her recognition through the Young Investigator Award at IPC-IPSCON 2025 further demonstrates professional acknowledgment of her contributions within the pharmacological research community.[3]

Her expertise in advanced laboratory techniques, coupled with her publication record and participation in international scientific activities, supports her suitability for academic recognition in the field of pharmacology and bone research. The interdisciplinary scope of her work aligns with contemporary priorities in therapeutic innovation and disease prevention.

Conclusion

Antra Chaudhary represents an emerging researcher in pharmacology whose scientific activities encompass bone pharmacology, oxidative stress biology, neuroprotection, and translational therapeutics. Through experimental research, scholarly publications, and active participation in scientific conferences, she has contributed to advancing knowledge in multiple biomedical domains. Her work continues to support the development of innovative therapeutic approaches aimed at improving disease management and bone health outcomes.[1]

References

  1. Jamia Hamdard University. (2026). Doctoral Research Profile of Antra Chaudhary.
  2. Jamia Hamdard University. (2026). Bone Pharmacology and Oxidative Stress Research Program.
  3. Elsevier. (2025). Pharmacological approaches in osteoporosis and translational therapeutics.
  4. Drug Discovery Today. (2022). Drug repurposing for stroke intervention.
    https://doi.org/10.1016/j.drudis.2022.03.014
  5. National Institute of Pharmaceutical Education and Research. (2020). MS Research Project Documentation.

Alireza Dehnad | Immunology and Microbiology | Excellence in Research Award

Published on by World Science Awards

Dr. Alireza Dehnad | Immunology and Microbiology | Excellence in Research Award

Department of Bacterial Diseases of Animals, Razi Vaccine and Serum Research Institute, Agricultural Research, Education and Extension Organization (AREEO), Karaj, Iran

Dr. Alireza Dehnad is an accomplished microbiologist and biotechnology researcher whose career spans over twenty-five years of impactful scientific work in veterinary microbiology, microbial biotechnology, and infectious disease research. With 88 Scopus-indexed publications, 2,503 citations, and an h-index of 27, he has demonstrated a consistent record of scholarly excellence, research productivity, and international recognition. His work encompasses diverse domains including microbial bioprocessing, secondary metabolite discovery, nanobiotechnology, antibiotic-producing Actinomycetes, viral and bacterial disease epidemiology, probiotics, wound healing applications, biopolymers for drug delivery, and microbial bioremediation. A major strength of Dr. Dehnad’s scientific career is his ability to bridge fundamental microbiology with translational biotechnology, generating research outputs that extend from laboratory innovation to real-world applications in human health, veterinary medicine, agriculture, and industrial biotechnology. He has contributed to notable advances in green nanoparticle synthesis, microbial metabolite-based therapeutics, pathogen surveillance, and probiotic industrialization. His experience supervising over 100 postgraduate theses and lecturing internationally reflects strong academic leadership, mentorship capacity, and global collaboration. Dr. Dehnad has earned prestigious national awards in recognition of his research contributions, including honors from the Razi Vaccine and Serum Research Institute and the Agricultural Biotechnology Research Institute. His leadership roles across scientific institutions, advisory committees, and biotechnology laboratories demonstrate institutional influence and commitment to advancing regional and national scientific infrastructure. While his research output is internationally visible and diverse, areas for continued development include expanding multi-center global collaborations, strengthening cross-disciplinary publications in high-impact journals, and increasing patent commercialization and industrial partnerships to further translate research outcomes into market-ready solutions.

Profiles: Scopus | ORCID

Featured Publications

Mahmoudi, F., Baradaran, B., Dehnad, A., Shanehbandi, D., Mohamed Khosroshahi, L., & Aghapour, M. (2016). The immunomodulatory activity of secondary metabolites isolated from Streptomyces calvus on human peripheral blood mononuclear cells. British Journal of Biomedical Science.

Khandan Nasab, N., Dehnad, A. R., Salimizand, H., Taherzadeh, D., Prakash, D., Verma, K. D., & Darroudi, M. (2016). Zinc selenide nanoparticles (ZnSe-NPs): Green synthesis and investigation of their cytotoxicity effects. Ceramics International.

Dehnad, A., Hamedi, J., Derakhshan-Khadivi, F., & Abusov, R. (2015). Green synthesis of gold nanoparticles by a metal resistant Arthrobacter nitroguajacolicus isolated from gold mine. IEEE Transactions on Nanobioscience.

Sadighbayan, K., Dehnad, A., Monadi, A., Mobaiyen, H., & Sadighbayan, D. (2013). An evaluation about the role of microorganisms isolated from the soil in the biological removal of toxic petroleum pollutants. Journal of Environmental Studies.

Sadigh-Eteghad, S., Dehnad, A., Mahmodi, J., Hoseyni, H., Khalili, I., & Razmaray II, N. (2013). Healing potential of a Streptomyces sp. secondary metabolite, SEM-1-111, on experimental full-thickness excision cutaneous wounds in Wistar rats. Clinical and Experimental Dermatology.

Gabriele Cortina | Medicine and Dentistry | Best Researcher Award

Published on by World Science Awards

Dr. Gabriele Cortina | Medicine and Dentistry | Best Researcher Award

Humanitas Castelli, Italy

Dr. Gabriele Cortina is an accomplished Orthopaedic and Traumatology Specialist recognized for his excellence in sports medicine, knee surgery, and joint reconstruction. He obtained his secondary diploma with distinction from Istituto Magistrale Luigi Pietrobono in Alatri (2006–2011) and earned his Laurea Magistrale a Ciclo Unico in Medicina e Chirurgia with 110/110 e lode from the Università Campus Bio-Medico di Roma in 2017, followed by professional qualification as a Medico-Chirurgo from Università degli Studi di Roma Tor Vergata (2018) and a specialization in Orthopaedics and Traumatology with 50/50 e lode from Campus Bio-Medico di Roma in 2023. Professionally, he serves as an orthopaedic surgeon at Cliniche Humanitas Gavazzeni-Castelli in Bergamo, Clinica Pierangeli in Pescara, and Clinica Santa Teresa in Isola del Liri, while also completing a prestigious Sport Medicine and Knee Surgery Fellowship at ICATME, Barcelona, under Prof. J.C. Monllau. His previous roles include specialization training at Humanitas Gavazzeni and Castelli Clinics and observerships in shoulder and hip surgery at Clinica Villa Verde (Fermo) and Villa Ulivella (Firenze). Dr. Cortina’s research interests focus on orthopaedic biomechanics, joint preservation, rehabilitation protocols, and regenerative therapies. His notable publications include studies on rotator cuff repair, osteoarthritis, kinematic knee alignment, and adipose tissue injection therapy in reputed journals such as The Knee, Osteology, Journal of Surgical Case Reports, and Journal of Experimental Orthopaedics. He is fluent in Italian and proficient in English and has actively participated in international conferences and cadaveric training courses across Europe, including SIAGASCOT, CADLAB Cologne, and M.O.R.E. Knee Learning Center. His research skills encompass clinical data analysis, surgical innovation, and multidisciplinary collaboration. Honors include multiple cum laude academic distinctions and recognition as a finalist in the LiGca-Lab Program by SIAGASCOT. In conclusion, Dr. Cortina embodies the fusion of clinical precision and academic depth, contributing to the advancement of modern orthopaedics through evidence-based practice, cross-border collaboration, and a lifelong commitment to improving musculoskeletal health.

Profiles: Scopus|ORCID

Featured Publications

  1. Cortina, G., Antuofermo, S. M., Papalia, G. F., Cortina, R., Condello, V., Perelli, S., Monllau, J. C., & Madonna, V. (2025). Limited clinical benefit of medial meniscus posterior root repair combined with high tibial osteotomy in varus knee osteoarthritis: A systematic review and meta‐analysis. Journal of Experimental Orthopaedics.
  2. Cortina, G., Collarile, M., Condello, V., Orlandi, R., Russo, A., Madonna, V., & Pieracci, N. (2021). Spinal hematoma after total knee arthroplasty: A case report. Journal of Surgical Case Reports.
  3. Berton, A., De Salvatore, S., Candela, V., Cortina, G., Lo Presti, D., Massaroni, C., Petrillo, S., & Denaro, V. (2020). Delayed rehabilitation protocol after rotator cuff repair. Osteology, 1(1), 3.
  4. Cortina, G. (2020). Physical activity for the treatment of chronic low back pain in elderly patients: A systematic review. Journal of Clinical Medicine, 9(4), 1023.
  5. Cortina, G. (2019). New trends in treatment of osteoarthritis: “From cells to metal”. A case report of simultaneous different approach to bilateral hip osteoarthritis. Annals of Case Report.

Dr. Gabriele Cortina’s work advances the field of orthopaedic science through innovative approaches in joint reconstruction, sports medicine, and regenerative therapy, bridging clinical excellence with translational research. His contributions enhance surgical outcomes, improve patient mobility, and foster global innovation in minimally invasive and evidence-based orthopaedic care.

Lei Li | Biomedical Engineering | Best Researcher Award

Published on by World Science Awards

Prof. Lei Li | Biomedical engineering | Best Researcher Award

Technical Institute of Physics and Chemistry, Chinese Academy of Sciences, China

Prof. Lei Li is a distinguished researcher in biomedical engineering, currently serving as Professor at the Technical Institute of Physics and Chemistry, Chinese Academy of Sciences, Beijing, China. He earned his Ph.D. in Biomedical Engineering from Tsinghua University in 2009, after completing a B.S. in Thermal Engineering at the same institution. His professional experience spans over 15 years, including roles as Assistant Professor (2012–2019), Associate Professor (2019–2024), and Professor (2024–present) at the Chinese Academy of Sciences, with international exposure as a Visiting Scholar at Massachusetts General Hospital, Harvard University (2015–2016) and a Research Associate at WPI Advanced Institute for Materials Research, Tohoku University (2010). Professor Li’s research focuses on liquid metal biomaterials, lab-on-a-chip systems for cell research, and biomedical microsystems, with expertise in developing flexible wireless stimulators, magnetically responsive 3D scaffolds, electromagnetic wave shielding films, and microfluidic chips for cell culture and drug screening. He possesses advanced research skills in nanofabrication, microfluidics, biomedical device development, and lab-on-a-chip technology, demonstrated through 39 publications with 936 citations and an h-index of 18, featured in leading journals including Advanced Functional Materials, Science China-Materials, Carbon, Biosensors and Bioelectronics, and International Journal of Biological Macromolecules. Professor Li has contributed to books and chapters in nanobiotechnology, supervised numerous students, and actively engages in mentorship and collaborative research projects internationally. His professional excellence is recognized through multiple awards and honors in the field of biomedical engineering and materials science. With a strong track record in innovation, leadership, and research impact, Professor Li continues to advance global biomedical research, with significant potential to expand high-impact publications, foster international collaborations, participate in keynote lectures, and guide the next generation of researchers, solidifying his role as a leading figure in biomedical microsystems and liquid metal biomaterials research.

Profile: Scopus

Featured Publications

  1. Hydrophilic hard-magnetic soft robots: A new approach for precise droplet manipulation. (2025). Nanotechnology and Precision Engineering.

  2. Purified adipose tissue-derived extracellular vesicles facilitate adipose organoid vascularization through coordinating adipogenesis and angiogenesis. (2025). Biofabrication.

  3. A biomimetic magnetically responsive scaffold with tunable and stable compression for dynamic 3D cell culture. (2025). Science China Materials.